A detailed history of Riggs Asset Managment Co. Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Riggs Asset Managment Co. Inc. holds 3 shares of MRNA stock, worth $197. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3
Holding current value
$197
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

BUY
$101.21 - $166.61 $303 - $499
3 New
3 $0
Q3 2022

Nov 08, 2022

BUY
$118.07 - $194.18 $11,807 - $19,418
100 New
100 $12,000
Q4 2021

Feb 02, 2022

SELL
$225.82 - $368.51 $2,935 - $4,790
-13 Closed
0 $0
Q3 2021

Nov 04, 2021

BUY
$221.9 - $484.47 $2,884 - $6,298
13 New
13 $5,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Riggs Asset Managment Co. Inc. Portfolio

Follow Riggs Asset Managment Co. Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Riggs Asset Managment Co. Inc., based on Form 13F filings with the SEC.

News

Stay updated on Riggs Asset Managment Co. Inc. with notifications on news.